The latest news from oncology events around the world
RANZCR Announces Annual Scientific Meeting 2022
The Royal Australian and New Zealand College of Radiologists (RANZCR) is pleased to announce that…
The latest news from oncology events around the world
The Royal Australian and New Zealand College of Radiologists (RANZCR) is pleased to announce that…
In a Phase II clinical trial, immune checkpoint blockade before surgery was associated with favourable…
The use of sacituzumab govitecan (Trodelvy) an antibody-drug conjugate, resulted in longer progression-free survival compared to…
Ibrutinib (Imbruvica) combined with bendamustine-rituximab improved progression-free survival by 50% for older patients with newly…
The addition of nimotuzumab to gemcitabine (Gemzar) increases overall survival in patients with K-Ras wild-type advanced pancreatic…
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the three-year…
The Australian-led clinical trial ENZAMET has shown that the addition of hormone therapy with a…
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
In patients with stage II colon cancer where cancer DNA was not present in the…
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug…